“Working on HIV clinical studies brings me a sense of personal fulfillment as we advance our pipeline. The size of the company allows me to feel the impact of the work I do each day and to see that I am contributing to the development of potentially safer and more effective treatments.”
Julie, Clinical Operations
In Clinical Operations, our effort is the largest it has ever been, with more than 200 active clinical studies evaluating compounds with the potential to become new therapies. We recognize the importance of internal and external partnership because it enhances our ability to develop innovative new medicines more efficiently.
At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.